Stay updated on Zenocutuzumab Clinical Trial in NRG1 Fusion
Sign up to get notified when there's something new on the Zenocutuzumab Clinical Trial in NRG1 Fusion page.

Latest updates to the Zenocutuzumab Clinical Trial in NRG1 Fusion page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has updated its partnership information, replacing Merus N.V. with Partner Therapeutics, Inc., and has also revised the version number from v2.15.0 to v2.15.2. Additionally, two dates have been added, indicating updates or events on April 25 and April 29, 2025.SummaryDifference1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has updated the study details for MCLA-128, including a new revision number and the addition of specific dates related to the study timeline. Notably, the previous detailed study design and inclusion/exclusion criteria have been removed, which may impact the clarity of the study's scope and participant requirements.SummaryDifference29%
- Check29 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 4, 2025.SummaryDifference0.2%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3.SummaryDifference0.2%
- Check59 days agoChange DetectedThe webpage has updated its date references, adding new dates in March 2025 while removing older dates from January and February 2025.SummaryDifference0.5%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Zenocutuzumab Clinical Trial in NRG1 Fusion
Enter your email address, and we'll notify you when there's something new on the Zenocutuzumab Clinical Trial in NRG1 Fusion page.